ArticleNPJ digital medicine2026
The Aloe Family recipe for open and specialized healthcare LLMs.
Article in NPJ digital medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Generative large language models in medicine: a scoping review of recent methodological advances.npj health systems · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
The growing interest in the application of Large Language Models (LLMs) for healthcare comes with a demand for better open-source LLMs, and stronger reassurances regarding their performance. To advance in this direction, this work conducts a thorough and transparent study of LLM model training and benchmarking in healthcare, releasing as open assets all resources needed for reproducing the Aloe models and its results (weights, data and code). This includes details on optimized data preprocessing and training, combining curated public data with synthetic samples for a total of 1.8B training tokens; enhanced safety, induced through Direct Preference Optimization (DPO), aligning Aloe models for ethical robustness and against jailbreaking attacks; and finally model performance, evaluated thoroughly through close-ended, open-ended, safety, and human assessments. To boost inference efficacy and test the upper bounds of open LLM performance, Aloe models are integrated with a Retrieval-Augmented Generation (RAG) system. The resultant models deliver competitive performance across healthcare benchmarks and medical fields while significantly improving safety and bias resilience. Model weights are released for research-only purposes, together with training and evaluation datasets, and RAG inference code. To enable the responsible release of such technology, this work is supported by a detailed healthcare-specific risk assessment. Building on top of base models like Llama 3.1 and Qwen 2.5, the Aloe models and their development recipe set a high standard for open-source medical LLMs, balancing top-tier performance with high ethical requirements.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.